Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07120945 · ClinicalTrials.gov registry record · NA
Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)
A NA study of Ovarian Cancer and Endometrial Cancer, sponsored by Medtronic - MITG.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 5
- Study locations
NCT07120945: Recruiting NA study of Ovarian Cancer and Endometrial Cancer, sponsored by Medtronic - MITG.
NCT07120945 is a NA study of Ovarian Cancer and Endometrial Cancer that is actively recruiting participants, run by Medtronic - MITG. The registered enrollment target is 70 participants, below the 729-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (90% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07120945, a NA study of Ovarian Cancer and Endometrial Cancer, is actively recruiting participants, sponsored by Medtronic - MITG.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this research is to evaluate the safety and performance of the investigational Medtronic Hugo™ Robotic Assisted Surgery (RAS) system when used during hysterectomy procedures, including patients being treated for cancer.
Primary Outcome
Surgical success rate is the procedure utilizing Hugo™ as outlined in the preoperatively defined surgical plan without conversion to an alternative robotic-assisted system, laparoscopy, or open surgery.
Conditions Studied
Interventions
- DEVICE Robotic Assisted-Surgery (RAS) Hysterectomy
Study Locations (5)
Florida
- Ascension St. Vincent's Riverside - Jacksonville
- The University of South Florida - Tampa
North Carolina
- Duke University - Durham
Pennsylvania
- Allegheny Health Network - West Penn - Pittsburgh
Washington
- Swedish Medical Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2025-08-28 |
| Est. Completion | 2031-05 |
| Phase | NA |
What NCT07120945 shows while recruiting
NCT07120945 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 729-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (90% lower).
The record links to 9 conditions, with Ovarian Cancer appearing as the primary indexed condition, and to 1 intervention - of which Robotic Assisted-Surgery (RAS) Hysterectomy is the first listed.
NCT07120945 lists 5 locations in 4 states (Florida, North Carolina, Pennsylvania).
Frequently Asked Questions
What is clinical trial NCT07120945 about?
NCT07120945 is a clinical study titled "Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)". The purpose of this research is to evaluate the safety and performance of the investigational Medtronic Hugo™ Robotic Assisted Surgery (RAS) system when used during hysterectomy procedures, including patients being treated for cancer.
What is the current status of trial NCT07120945?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2025-08-28. Estimated completion is 2031-05.
What conditions does trial NCT07120945 study?
This clinical trial studies the following conditions: Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Endometriosis, Uterine Prolapse.
What interventions are being tested in trial NCT07120945?
The interventions under investigation include: Robotic Assisted-Surgery (RAS) Hysterectomy (DEVICE).
Who is sponsoring clinical trial NCT07120945?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07120945 being conducted?
This trial has 5 study locations across Florida, North Carolina, Pennsylvania, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ovarian Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07120945's enrollment target sits among peer trials
70 177th of 322 higher than 140 of 322 other Ovarian Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ovarian Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer
RECRUITING · NA
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
RECRUITING · NA
-
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
RECRUITING · NA
-
Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI